K. Looi

发表

Long‐term outcomes of heart failure patients who received primary prevention implantable cardioverter‐defibrillator: An observational study

N. Lever, K. Sidhu, K. Looi, 2017, Journal of arrhythmia.

Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.

F. Khan, P. Gajendragadkar, S. Barra, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Utilization of cardiac resynchronization therapy in patients with heart failure in the Northern Region of New Zealand

N. Lever, K. Sidhu, K. Looi, 2018, Journal of arrhythmia.

Outcomes of patients with heart failure after primary prevention ICD unit generator replacement

N. Lever, K. Looi, Lisa Cooper, 2019, Heart Asia.

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)

R. Jackson, A. Kerr, M. Stiles, 2019, Journal of arrhythmia.

Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator

S. Agarwal, A. Tang, K. Looi, 2015, Postgraduate Medical Journal.

All that is irregular is not AF!

A. Kanthan, K. Looi, Colin Machado, 2014, The Medical journal of Australia.

Adherence to the current guidelines for bradycardic pacing in the octogenarian and nonagenarian populations.

J. Pemberton, K. Looi, Vivienne Kim, 2016, The New Zealand medical journal.

Coronary artery spasm and ventricular arrhythmias

S. Agarwal, K. Looi, A. Grace, 2012, Postgraduate Medical Journal.

Gender differences in the use of primary prevention ICDs in New Zealand patients with heart failure

N. Lever, K. Sidhu, K. Looi, 2018, Heart Asia.

Use of Cardiac Resynchronisation Therapy - Change of Clinical Settings.

S. Agarwal, A. Tang, K. Looi, 2014, Arrhythmia & electrophysiology review.

LV epicardial lead placement at time of cardiac surgery: useful for some-but not all.

T. Wang, N. Lever, K. Looi, 2018, The New Zealand medical journal.

Utility of Cardiac Magnetic Resonance in the Evaluation of Unselected Patients with Possible Arrhythmogenic Right Ventricular Cardiomyopathy

J. Christiansen, C. Edwards, H. Hart, 2012, Clinical Medicine Insights. Cardiology.

S pneumoniae purulent pericarditis in the setting of community-acquired pneumonia.

A. Chatfield, K. Looi, S. Fitzsimons, 2017, The New Zealand medical journal.

A case of cardiogenic shock caused by capecitabine treatment

H. White, D. Damianovich, A. To, 2008, Nature Clinical Practice Cardiovascular Medicine.

Ten‐year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS‐QI 51)

R. Jackson, A. Kerr, K. Poppe, 2020, Internal medicine journal.

Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54)

R. Jackson, A. Kerr, K. Poppe, 2020, Internal medicine journal.

A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study).

P. Sanders, A. McLellan, S. Azzopardi, 2015, European heart journal.

Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation

M. Elsik, P. Gajendragadkar, D. Begley, 2012, Journal of Interventional Cardiac Electrophysiology.

Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure

J. Le Heuzey, É. Marijon, J. Deharo, 2017, Heart.

Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.

J. Le Heuzey, É. Marijon, K. Narayanan, 2017, Journal of the American College of Cardiology.

Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?

N. Lever, S. Agarwal, A. Tang, 2017, Heart Failure Reviews.

Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.

H. White, C. Ellis, M. Lee, 2011, The New Zealand medical journal.

Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand

R. Doughty, N. Lever, K. Looi, 2019, BMJ Open.

Conscious sedation and analgesia use in cardiac device implantation.

A. Grace, S. Agarwal, D. Begley, 2013, International journal of cardiology.

Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function

A. Grace, M. Elsik, F. Khan, 2014, Heart.